Megacort‑16 Tablets are an anti-inflammatory corticosteroid containing Methylprednisolone IP 16 mg. It functions by modulating immune responses and reducing inflammation through inhibition of leukocyte infiltration, cytokine release, and prostaglandin synthesis.
Allergic reactions (urticaria, asthma exacerbations)
Autoimmune conditions such as rheumatoid arthritis or lupus flare-ups
Inflammatory dermatological conditions and acute respiratory inflammation
Short-term use in acute asthma or inflammatory disease exacerbations
Rapid and potent reduction of inflammation and allergic symptoms
Controllable immunosuppression with short courses
Widely used under medical supervision for acute steroid-responsive conditions
Dose and duration depend on severity. Usually prescribed as tapering oral regimen over days or weeks per physician’s guidance. Take with food to minimize gastric irritation.
Avoid long-term use due to potential for immunosuppression, osteoporosis, and adrenal suppression
Monitor blood glucose in diabetic patients
Not suitable during active infections unless covered by antibiotics
May cause weight gain, mood changes, or swelling
Keep in original blister pack, below 25 °C, away from moisture. Keep medication out of children’s reach.
Megacort‑16 provides reliable, immediate relief in acute inflammatory and allergic conditions when used under medical supervision.
